Form D · Pharmaceuticals

CHINA BAICAOTANG MEDICINE Ltd

Guangxi Province, F4 · CIK 0001399356

Offering snapshot reported Feb 12, 2010 · SEC filing

Reported sold: $8.94M
Investors reported: 133
Minimum accepted: $0
First sale: Dec 30, 2009

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$6,323,002 → $8,939,130
Reported investors102 → 133

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Feb 12, 2010	Amendment	$8,939,130	$2,616,128vs Jan 8, 2010	133	SEC filing
Jan 8, 2010	Initial	$6,323,002	No comparison	102	SEC filing

Offering details

Securities: Not reported
Exemptions: 06
Duration over one year: No
Business combination: Yes

Sales commissions: $894K
Finders' fees: $0
Form D file number: 021-137574

Not including a 3% non-accountable allowance of $268,174

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Owen A. May	1404710	May Davis Partners, LLC · CRD 140988
American Capital Partners LLC	119249
Charles Vista LLC	132650
Zhongyu Zhou	5547121	May Davis Partners, LLC · CRD 140988

Source: Form D, filed Feb 12, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Huitian Tang	Director, Executive
Xiaoyan Zhang	Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

No. 102, Chengzhan Road Liuzhou City
Guangxi Province, F4, 545000